DaVita stock price forecast: Ozempic sell-off is an overreaction
DaVita (NYSE: DVA) stock price has come under intense pressure in the past few days. The stock made a big dive on October 9th and crashed to a multi-month low of $71.45. While it has bounced back slightly, it remains 30% below the highest level this year. Similarly, Baxter, its close competitor, has plunged by […]